Product Overview

Temsujohn 0.4 contains Tamsulosin Hydrochloride, a selective alpha-1 adrenergic receptor antagonist formulated in a modified-release dosage form for the effective management of Benign Prostatic Hyperplasia (BPH). It is widely prescribed to relieve lower urinary tract symptoms (LUTS) associated with an enlarged prostate, including difficulty in urination, weak urinary stream, urinary hesitancy, increased urinary frequency, nocturia, and the sensation of incomplete bladder emptying.

The modified-release formulation ensures a controlled release of Tamsulosin throughout the day, providing sustained symptom relief with convenient once-daily dosing. By relaxing the smooth muscles of the prostate and bladder neck, Temsujohn 0.4 improves urinary flow without reducing the size of the prostate, helping patients achieve better bladder function and improved quality of life.

Manufactured under stringent pharmaceutical quality standards, Temsujohn 0.4 offers consistent efficacy, safety, and reliability, making it a trusted therapeutic option in modern urological care.

How It Works

Tamsulosin Hydrochloride selectively blocks alpha-1 adrenergic receptors located in the smooth muscles of the prostate, bladder neck, and urethra. This relaxation reduces urinary outflow resistance, allowing urine to pass more freely and improving bladder emptying. The modified-release formulation provides sustained therapeutic action, ensuring effective symptom control throughout the day.

Therapeutic Applications

Temsujohn 0.4 may be prescribed for the management of:

• Benign Prostatic Hyperplasia (BPH)
• Lower Urinary Tract Symptoms (LUTS)
• Difficulty in Urination
• Weak Urinary Stream
• Urinary Hesitancy
• Frequent Urination
• Nocturia
• Incomplete Bladder Emptying

Key Benefits

• Modified-release formulation for sustained symptom control.
• Improves urine flow and bladder emptying.
• Helps reduce urinary urgency, frequency, and nocturia.
• Relieves lower urinary tract symptoms associated with BPH.
• Convenient once-daily dosing.
• Manufactured under stringent pharmaceutical quality standards.

Quality Commitment

Vinix Biopharma is committed to delivering high-quality urology products manufactured in accordance with stringent pharmaceutical quality standards. Temsujohn 0.4 undergoes comprehensive quality assurance procedures and rigorous testing to ensure safety, efficacy, consistency, and reliability. Every batch is carefully evaluated to maintain product integrity and support optimal patient care.

Storage Information

Store in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Disclaimer

Temsujohn 0.4 should be used only under the supervision of a qualified healthcare professional. Dosage and duration of treatment should be determined by the treating physician based on the patient’s clinical condition, medical history, and therapeutic requirements.